World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
12933
World Ranking
13733
National Ranking
30

Petros I. Rafailidis publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Petros I. Rafailidis sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 130 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Petros I. Rafailidis D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Petros I. Rafailidis sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Petros I. Rafailidis is affiliated with Democritus University of Thrace in Greece and has contributed extensively to the field of Medicine, with a particular focus on Infectious Diseases, Applied Microbiology and Biotechnology, Pharmacology, Neurology, and Immunology. Their research emphasizes antibiotic resistance, infectious disease management, and immunological mechanisms related to bacterial infections and COVID-19.

Their frequent research topics include:

  • Antibiotic Use and Resistance
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Inflammasome and Immune Disorders
  • Antibiotics Pharmacokinetics and Efficacy
  • Nosocomial Infections in ICU

Rafailidis has collaborated regularly with several coauthors, including:

  • Vasileios Petrakis (9 collaborations)
  • Dimitrios Papazoglou (8 collaborations)
  • Maria Panopoulou (7 collaborations)
  • Periklis Panagopoulos (6 collaborations)
  • Irene Terzi (6 collaborations)

Their publications appear predominantly in these venues:

  • Infezioni in Medicina (3 papers)
  • bioRxiv (Cold Spring Harbor Laboratory) (2 papers)
  • Expert Review of Anti-infective Therapy (2 papers)
  • Virology (2 papers)
  • Journal of Clinical Investigation (1 paper)

Key recent papers authored or coauthored by Rafailidis include:

  • "Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria," 2021, Expert Review of Anti-infective Therapy
  • "Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections," 2024, Antibiotics

Additional notable papers associated with their frequent collaborators, particularly related to COVID-19, include:

  • "Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis," 2020, Journal of Clinical Investigation
  • "Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis," 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • "The Impact of the COVID-19 Pandemic on Antimicrobial Resistance and Management of Bloodstream Infections," 2023, Pathogens

Rafailidis's work addresses complex interactions between infectious agents and immune responses, with particular attention to multidrug-resistant bacteria and clinical therapeutic strategies. Their research also explores the implications of the COVID-19 pandemic on antimicrobial resistance dynamics and infection control in clinical settings.

Best Publications

  • Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.

    Petros I Rafailidis;Eleni G Mourtzoukou;Ioannis C Varbobitis;Matthew E Falagas;Matthew E Falagas

  • Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.

    Panagiotis Skendros;Alexandros Mitsios;Akrivi Chrysanthopoulou;Dimitrios C. Mastellos

  • β-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

    Drosos E. Karageorgopoulos;Evridiki K. Vouloumanou;Fotinie Ntziora;Argyris Michalopoulos

  • Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence

    Matthew E. Falagas;Panagiota Lourida;Panagiotis Poulikakos;Petros I. Rafailidis

  • Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis

    Konstantinos Z. Vardakas;Giannoula S. Tansarli;Petros I. Rafailidis;Matthew E. Falagas;Matthew E. Falagas

  • Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections

    Matthew E. Falagas;Konstantina P. Giannopoulou;George N. Kokolakis;Petros I. Rafailidis

  • Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

    Matthew E. Falagas;Matthew E. Falagas;Petros I. Rafailidis;Elda Ioannidou;Vangelis G. Alexiou

  • Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence

    Theodore Kelesidis;Iosif Kelesidis;Petros I. Rafailidis;Matthew E. Falagas;Matthew E. Falagas

  • Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study

    Matthew E Falagas;Matthew E Falagas;Petros I Rafailidis;Diamantis Kofteridis;Simona Virtzili

  • Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.

    Konstantinos Z. Vardakas;Konstantinos A. Polyzos;Konstantina Patouni;Petros I. Rafailidis

  • Attributable mortality of Acinetobacter baumannii: no longer a controversial issue

    Matthew E Falagas;Petros I Rafailidis

  • Worldwide prevalence of head lice.

    Matthew E. Falagas;Dimitrios K. Matthaiou;Petros I. Rafailidis;George Panos

  • The effect of psychosocial factors on breast cancer outcome: a systematic review.

    Matthew E Falagas;Matthew E Falagas;Effie A Zarkadoulia;Eleni N Ioannidou;George Peppas

  • Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study

    Nikolaos Markou;Sophia L Markantonis;Efthimios Dimitrakis;Dimitris Panidis

  • Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies

    Matthew E. Falagas;Matthew E. Falagas;Antonia C. Kastoris;Drosos E. Karageorgopoulos;Petros I. Rafailidis

  • Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation

    A. Michalopoulos;S. Virtzili;P. Rafailidis;G. Chalevelakis

  • Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials

    Matthew E. Falagas;Evridiki K. Vouloumanou;Antonios G. Togias;Maria Karadima

  • Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials.

    Matthew E. Falagas;Ioannis K. Kotsantis;Evridiki K. Vouloumanou;Petros I. Rafailidis

  • Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?

    Konstantinos Z. Vardakas;Petros I. Rafailidis;Athanasios A. Konstantelias;Athanasios A. Konstantelias;Matthew E. Falagas;Matthew E. Falagas

  • Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study.

    Dimitrios K. Matthaiou;Argyris Michalopoulos;Petros I. Rafailidis;Drosos E. Karageorgopoulos

Frequent Co-Authors

Matthew E. Falagas
Matthew E. Falagas Alfa Institute of Biomedical Sciences
George Dimopoulos
George Dimopoulos National and Kapodistrian University of Athens
Paschalis Sideras
Paschalis Sideras Academy of Athens
George Samonis
George Samonis University of Crete
Dimitrios T. Boumpas
Dimitrios T. Boumpas National and Kapodistrian University of Athens
John D. Lambris
John D. Lambris University of Pennsylvania
Jordi Rello
Jordi Rello Instituto de Salud Carlos III
George V. Papatheodoridis
George V. Papatheodoridis National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your career options with a background in Biology or Biochemistry? Many students are now turning to flexible programs that align with their goals and schedules. For those seeking to enter healthcare quickly, enrolling in an online medical assisting school is a popular first step. These programs often offer financial aid and can prepare you for immediate employment in clinical settings.

If you’re already a medical assistant, you might consider an medical assistant to lpn bridge program. This pathway can lead to broader responsibilities and higher earning potential by helping you become a Licensed Practical Nurse (LPN).

For those interested in more in-depth science, earning a bs in biology online could open doors to research, laboratory work, or further graduate studies. Likewise, pursuing an online asn is an excellent way to start a nursing career with the flexibility that online learning provides.

With these diverse online pathways, you can tailor your education to meet your career goals in the fields of biology, biochemistry, and healthcare.

Best Scientists Citing Petros I. Rafailidis

Trending Scientists

Recently Published Articles